Print

Australia's Mayne Pharma Limited Faces A$2 Billion Takeover Bid  
9/20/2006 8:09:16 AM

MELBOURNE, Sept 20 (Reuters) - Australian cancer drugs maker Mayne Pharma Ltd. (MYP.AX: Quote, Profile, Research) has received an over A$2 billion ($1.5 billion) takeover approach from an international rival, the Australian Financial Review newspaper reported on Wednesday.

>>> Discuss This Story


//-->